Fierce Pharma

OCTOBER 22, 2023

Lennon and McCartney. Simon and Garfunkel. Richards and Jagger. Padcev and Keytruda? Can the cancer-fighting duo rock on in bladder cancer? | The results are in for a phase 3 bladder cancer trial assessing the combination of Seagen and Astellas' Padcev, plus Merck's Keytruda, versus standard of care chemotherapy. The figures indicate that the combo can be transformative in the indication.

255

255

MedCity News

OCTOBER 22, 2023

Patient safety and lack of autonomy are two of the biggest factors driving so many clinicians away from the medical field, according to a new EY report. Clinicians feel like they aren’t able to provide patients with the quality of care they need and deserve due to workforce shortages, resource constraints, and health system policies over which they have no control.

Safety 122

Safety Medical Patients 122

Fierce Pharma

OCTOBER 22, 2023

MADRID—Attendees for the European Society for Medical Oncology Congress 2023 arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitem | ESMO attendees arrived in Madrid to torrential downpours Thursday evening, a gloomy atmosphere that did not reflect the overall excitement of an industry conference that promised to showcase breakthroughs in breast, lung and prostate cancer.

Medical 229

Medical 229

MedCity News

OCTOBER 22, 2023

In submitted comments to the Departments of Health and Human Services, Treasury and Labor, AHIP argued that the proposed mental health parity rule would not expand access to mental health support. It believes the rule should be withdrawn altogether.

114

114

Advertisement

Distribution

Fierce Pharma

OCTOBER 22, 2023

Novartis has high hopes for its radiotherapy Pluvicto. | As Novartis aims to move its radiotherapy Pluvicto into an earlier treatment setting in prostate cancer, it has posted a mixed bag of trial data that cast a cloud of uncertainty over its regulatory path forward.

173

173

MedCity News

OCTOBER 22, 2023

Obesity management solutions offer a middle path for patients and providers. They help mitigate cost trends for payers and employers while maintaining access and providing equitable care to members and employees.

Management 106

Management Medical Patients Biopharma 106

PharmaTech

OCTOBER 22, 2023

According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. With pharma having discovered the pitfalls of individual solutions, many are building a new clinical trial technology foundation that can better scale according to their needs. Hear from four top minds across pharma and discover what the next model of clinical conduct looks like, what it does for sites and patients, and why foundational platforms are criti

Pharma 52

Pharma Marketing Patients 52

Cesare Ferrari

OCTOBER 22, 2023

I recently met an ex-colleague and we discussed for a couple of hours several decisions made by the management of a MedTech company that we both felt were not focused on the customer. We agreed that those decisions were evidence of putting the business needs over what was best for the customer.    For this reason, after this eye-opening conversation about how far small and medium-sized medical device companies are from being customer-centric, I decided to return to this topic.

Medical 52

Medical Sales Doctors Management 52

PharmaTech

OCTOBER 22, 2023

Various factors must be considered when it comes to developing and delivering high-quality pharmaceutical drug products or medical devices to end users. A CDMO can help ensure products maintain quality standards and are readily available as necessitated throughout development, manufacturing, and commercialization.

Pharmaceutical 52

Pharmaceutical Manufacturing Medical 52

pharmaphorum

OCTOBER 22, 2023

ESMO: Opdivo chases Keytruda in perioperative lung cancer Phil.

67

67

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTech

OCTOBER 22, 2023

There are many reasons behind the success of a technology transfer. But at the center of this complexity is one critical role: project management in the tech transfer.

Management 52

Management 52

MedCity News

OCTOBER 22, 2023

The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses all of them in a single vaccine, making dosing easier for patients.

FDA 115

FDA Patients Biopharma Pharma 115

PharmaTech

OCTOBER 22, 2023

Process equipment used in the healthcare and pharmaceutical industries follow rigid specifications for accuracy, consistency and cleanliness.

Pharmaceutical 52

Pharmaceutical Medical Healthcare Healthcare 52

PharmaTech

OCTOBER 22, 2023

According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. In this free guide, we delve into the exciting world of DCTs and explore how they are reshaping the landscape of medical research. As technology advances and the need for more efficient and patient-centric approaches to clinical trials grows, DCTs have emerged as a powerful solution.

Electronics 40

Electronics Recruitment Healthcare Healthcare 40

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaTech

OCTOBER 22, 2023

Over the last decade the number of oncology trials has skyrocketed, almost doubling the number of all other therapeutic areas combined, according to the WIRB-Copernicus Group¹. Known for their complex design, oncology trials often present various participant, site, and sponsor hurdles. Sponsors and CROs looking to tackle these challenges and reduce the burden on participants and sites should explore the potential of digital solutions, particularly electronic informed consent (eConsent) and elect

Electronics 40

Electronics Patients 40

PharmaTech

OCTOBER 22, 2023

Webinar Date/Time: Thursday, Nov 30, 2023 at 11:00 AM EST

52

52